Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2 | Q05397 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 16/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.44 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.44 |
| ▸ | NUAK2 | Q9H093 | 2/20 | 0.43 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30380211 | 0.96 | PTK2 (0.51) | PTK2EGFRNUAK2NUAK1IGF1R | |
| SCHEMBL28531524 | 0.96 | PTK2 (0.51) | PTK2EGFRNUAK2NUAK1IGF1R | |
| SCHEMBL30379302 | 0.83 | SLC2A1 (0.47) | PTK2EGFRPLK1PLK3PLK2 | |
| SCHEMBL21600825 | 0.81 | EGFR (0.44) | PTK2EGFRNUAK2NUAK1IGF1R | |
| SCHEMBL21596338 | 0.80 | FGFR4 (0.51) | PTK2EGFRNUAK2NUAK1 | |
| SCHEMBL28532459 | 0.80 | FGFR1 (0.49) | PTK2EGFRPLK1IGF1RCDK2 | |
| SCHEMBL30379611 | 0.80 | FGFR1 (0.49) | PTK2EGFRPLK1IGF1RCDK2 | |
| SCHEMBL28533769 | 0.78 | ALK (0.56) | PTK2EGFRPLK1IGF1R | |
| SCHEMBL28953571 | 0.78 | ALK (0.58) | PTK2EGFRPLK1NUAK1IGF1R | |
| SCHEMBL28909332 | 0.78 | IGF1R (0.52) | PTK2PLK1PLK3PLK2IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019242689-A1 | CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | 北京赛特明强医药科技有限公司 | 2019-12-26 | — | — | WO | disclosed |